UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annual review of medicine, ISSN 0066-4219, 1/2017, Volume 68, Issue 1, pp. 255 - 269
IL-17 antagonists | TNF antagonists | psoriasis vulgaris | biologic drugs | IL-23 antagonists | cytokines | polar T cell subsets | pathogenesis of psoriasis | Polar T cell subsets | Psoriasis vulgaris | Cytokines | Pathogenesis of psoriasis | Biologic drugs | Psoriasis - immunology | Interleukin-23 Subunit p19 - antagonists & inhibitors | Psoriasis - drug therapy | Dendritic Cells - immunology | Humans | HLA Antigens - immunology | Dermatologic Agents - therapeutic use | Interleukin-12 Subunit p40 - antagonists & inhibitors | Th17 Cells - drug effects | Interleukin-17 - antagonists & inhibitors | Interleukin-23 - antagonists & inhibitors | Th17 Cells - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Psoriasis | Interleukins | Physiological aspects | Genetic aspects | Research | T cells | Drug therapy | Index Medicus
Journal Article
Journal of Crohn's and colitis, ISSN 1873-9946, 2018, Volume 12, Issue 1, pp. 105 - 119
Inflammatory bowel disease | Therapy | TNF antagonists | Sphingosine-1 phosphate | IL-23 antagonists | JAK inhibitors | Smad7 | Pipeline | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Immunoglobulins | Antibodies, Monoclonal, Humanized - therapeutic use | Smad7 Protein - antagonists & inhibitors | Humans | Immunosuppressive Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Adrenal Cortex Hormones - therapeutic use | Molecular Targeted Therapy | Janus Kinases - antagonists & inhibitors | Algorithms | Interleukin-23 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Crohn Disease - drug therapy | Interleukin-12 - antagonists & inhibitors | Vascular Cell Adhesion Molecule-1 - antagonists & inhibitors | Colitis, Ulcerative - drug therapy | Drug Therapy, Combination | Mucoproteins - antagonists & inhibitors | Integrins - antagonists & inhibitors | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 08/2016, Volume 175, Issue 2, pp. 247 - 248
Journal Article
Trends in immunology, ISSN 1471-4906, 2017, Volume 38, Issue 4, pp. 229 - 231
Allergy and Immunology | Life Sciences & Biomedicine | Immunology | Science & Technology | Autoimmunity | Interleukin-17 - metabolism | Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors | Animals | Interleukin-23 - metabolism | Autoantigens - immunology | Humans | Th17 Cells - immunology | Mice | Thymocytes - immunology | Substance abuse treatment | Cytokines | CD8 antigen | Interleukin | Helper cells | T cell receptors | Lymphocytes T | Inflammation | Gene expression | Thymus | CD4 antigen | Thymocytes | Lymphocytes | Rodents | Ligands | Autoimmune diseases | Retinoic acid | Apoptosis | Index Medicus
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 08/2019, Volume 39, Issue 8, pp. 1510 - 1519
Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Animals | Interleukin-6 - antagonists & inhibitors | Interleukin-17 - antagonists & inhibitors | Interleukin-23 - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Cytokines - antagonists & inhibitors | Thrombosis - prevention & control | Atherosclerosis - prevention & control | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Interleukin-1beta - antagonists & inhibitors | Index Medicus
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 5/2020, Volume 8, Issue 1, p. e000930
Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Inflammation - pathology | Interleukin-6 - antagonists & inhibitors | Pandemics | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Antibodies, Monoclonal - therapeutic use | Respiratory Distress Syndrome - immunology | Adoptive Transfer | COVID-19 | Inflammation - complications | Neoplasms - therapy | Respiratory Distress Syndrome - complications | Societies, Medical | Inflammation - drug therapy | Interleukin-23 - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - pharmacology | Immunotherapy | Pneumonia, Viral - complications | Interferon-gamma - antagonists & inhibitors | Coronavirus Infections - complications | Respiratory Distress Syndrome - drug therapy | Cytokine Release Syndrome - drug therapy | Interleukin-1 - antagonists & inhibitors | Interleukin-6 - metabolism | Cytokine Release Syndrome - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Interleukin-6 - genetics | Antibodies, Monoclonal - pharmacology | Pneumonia, Viral - pathology | Cytokine Release Syndrome - complications | Inflammation - immunology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Janus Kinases - antagonists & inhibitors | Respiratory Distress Syndrome - pathology | Interleukin-17 - antagonists & inhibitors | Signal Transduction - drug effects | Neoplasms - immunology | Cytokine Release Syndrome - pathology | Coronavirus Infections - pathology | Interleukin-6 - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - antagonists & inhibitors | STAT Transcription Factors - antagonists & inhibitors | Severe Acute Respiratory Syndrome - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus
Journal Article
Expert opinion on investigational drugs, ISSN 1354-3784, 05/2019, Volume 28, Issue 5, pp. 473 - 479
interleukin-12/23 | ustekinumab | risankizumab | Crohn's disease | ulcerative colitis | brazikumab | guselkumab | inflammatory bowel disease | interleukin-12 | interleukin-23 | mirizumab | Crohn’s disease | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Gastrointestinal Agents - pharmacology | Animals | Interleukin-23 - antagonists & inhibitors | Crohn Disease - drug therapy | Humans | Interleukin-12 - antagonists & inhibitors | Ustekinumab - pharmacology | Crohn Disease - physiopathology | Gastrointestinal Agents - adverse effects | Colitis, Ulcerative - drug therapy | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Colitis, Ulcerative - physiopathology | Index Medicus
Journal Article
Proteins, structure, function, and bioinformatics, ISSN 0887-3585, 06/2014, Volume 82, Issue 6, pp. 975 - 989
cytokine | protein scaffold | ribosome display | engineered binding protein | psoriasis | combinatorial library | Protein scaffold | Psoriasis | Engineered binding protein | Combinatorial library | Cytokine | Ribosome display | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Binding, Competitive | Amino Acid Sequence | Immunologic Factors - chemistry | Receptors, Interleukin - physiology | Anti-Inflammatory Agents - pharmacology | Jurkat Cells | Humans | Bacterial Proteins - chemistry | Molecular Sequence Data | Peptide Fragments - pharmacology | Receptors, Interleukin - antagonists & inhibitors | Sequence Homology, Amino Acid | Peptide Fragments - chemistry | Th17 Cells - drug effects | Anti-Inflammatory Agents - chemistry | Th17 Cells - metabolism | K562 Cells | Interleukin-23 - chemistry | Protein Binding | Drug Evaluation, Preclinical | Interleukin-23 - physiology | Immunologic Factors - pharmacology | Interleukins | Leukemia | Albumin | Chemical properties | T cells | Binding proteins | Protein binding | Index Medicus
Journal Article